MedPage Today on MSN
Crohn's Disease Guideline Recommends Early Use of High-Efficacy Drugs
T reatment of moderate-to-severe Crohn's disease should prioritize early use of higher-efficacy advanced therapies rather ...
The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...
News-Medical.Net on MSN
AGA issues updated guidance for pharmacologic treatment of moderate-to-severe Crohn's disease
The (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.
The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...
A clinical trial delivering hope to people living with inflammatory bowel disease (IBD) has reached an important milestone, with initial results ...
Women with inflammatory bowel disease (IBD) are three times more likely to forgo having children than people without the ...
6d
AdventHealth Tampa performs nation's first single port robotic rectal resection and pouch creation
People living with inflammatory bowel disease (IBD) now have access to one of the newest, most advanced and minimally ...
SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic autoimmune diseases, today announced that the Centers for Medicare & Medicaid ...
Tyruko ® was developed by Polpharma Biologics and will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. The launch marks a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback